SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Anwar Mohiemen)
 

Search: WFRF:(Anwar Mohiemen) > (2022) > Ixovex-1, a novel o...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Anwar, MohiemenChelsea & Westminster NHS Fdn Trust, ENT Dept, London, England. (author)

Ixovex-1, a novel oncolytic E1B-mutated adenovirus

  • Article/chapterEnglish2022

Publisher, publication year, extent ...

  • 2022-05-20
  • Springer Nature,2022
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-489962
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-489962URI
  • https://doi.org/10.1038/s41417-022-00480-3DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • There is a great demand for improved oncolytic viruses that selectively replicate within cancer cells while sparing normal cells. Here, we describe a novel oncolytic adenovirus, Ixovex-1, that obtains a cancer-selective replication phenotype by modulating the level of expression of the different, alternatively spliced E1B mRNA isoforms. Ixovex-1 is a recombinant adenovirus that carries a single point mutation in the E1B-93R 3' splice acceptor site that results in overexpression of the E1B-156R splice isoform. In this paper, we studied the characteristics of this novel oncolytic adenovirus by validating its in vitro behaviour in a panel of normal cells and cancer cells. We additionally studied its anti-tumour efficacy in vivo. Ixovex-1 significantly inhibited tumour growth and prolonged survival of mice in an immune-deficient lung carcinoma tumour implantation model. In complementation experiments, overexpression of E1B-156R was shown to increase the oncolytic index of both Ad5wt and ONYX-015. In contrast to prior viruses of similar type, Ixovex-1 includes a functional E3B region for better in vivo efficacy. Throughout this study, the Ixovex-1 virus has been proven to be superior in competency compared to a virus with multiple deletions.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Arendt, Maja-LouiseUniv Copenhagen, Dept Vet Clin Sci, Copenhagen, Denmark. (author)
  • Ramachandran, Mohanraj,1988-Uppsala universitet,Cancerimmunterapi(Swepub:uu)mohra272 (author)
  • Carlsson, AnetteUppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi(Swepub:uu)aca31040 (author)
  • Essand, MagnusUppsala universitet,Cancerimmunterapi(Swepub:uu)magnessa (author)
  • Akusjärvi, Göran,1953-Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi(Swepub:uu)gak30132 (author)
  • Alusi, GhasanIxogen Ltd, London, England. (author)
  • Öberg, DanielUppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi(Swepub:uu)daobe475 (author)
  • Chelsea & Westminster NHS Fdn Trust, ENT Dept, London, England.Univ Copenhagen, Dept Vet Clin Sci, Copenhagen, Denmark. (creator_code:org_t)

Related titles

  • In:Cancer Gene Therapy: Springer Nature29:11, s. 1628-16350929-19031476-5500

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view